Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. [electronic resource] by
- Bender, David
- Sill, Michael W
- Lankes, Heather A
- Reyes, Henry D
- Darus, Christopher J
- Delmore, James E
- Rotmensch, Jacob
- Gray, Heidi J
- Mannel, Robert S
- Schilder, Jeanne M
- Hunter, Mark I
- McCourt, Carolyn K
- Samuelson, Megan I
- Leslie, Kimberly K
Producer: 20151229
In:
Gynecologic oncology vol. 138
Availability: No items available.
|